Close Menu

Researchers at Massachusetts General Hospital have developed a microfluidics chip that captures rare cancer cells in numbers that are high enough to enable analysis for molecular markers, reports Technology Review's Emily Singer. The device could save patients the hassle and pain of tumor biopsies since a sufficient number of cells could be culled from the bloodstream, and doctors could pick better drugs for their patients by doing the molecular marker analysis, she adds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.